Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel
- PMID: 20833142
- PMCID: PMC3215091
- DOI: 10.1016/j.bbrc.2010.09.008
Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel
Abstract
The M2 protein of influenza A virus forms a proton-selective channel that is required for viral replication. It is the target of the anti-influenza drugs, amantadine and rimantadine. Widespread drug resistant mutants, however, has greatly compromised the effectiveness of these drugs. Here, we report the solution NMR structure of the highly pathogenic, drug resistant mutant V27A. The structure reveals subtle structural differences from wildtype that maybe linked to drug resistance. The V27A mutation significantly decreases hydrophobic packing between the N-terminal ends of the transmembrane helices, which explains the looser, more dynamic tetrameric assembly. The weakened channel assembly can resist drug binding either by destabilizing the rimantadine-binding pocket at Asp44, in the case of the allosteric inhibition model, or by reducing hydrophobic contacts with amantadine in the pore, in the case of the pore-blocking model. Moreover, the V27A structure shows a substantially increased channel opening at the N-terminal end, which may explain the faster proton conduction observed for this mutant. Furthermore, due to the high quality NMR data recorded for the V27A mutant, we were able to determine the structured region connecting the channel domain to the C-terminal amphipathic helices that was not determined in the wildtype structure. The new structural data show that the amphipathic helices are packed much more closely to the channel domain and provide new insights into the proton transfer pathway.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures





Similar articles
-
Structure and mechanism of the M2 proton channel of influenza A virus.Nature. 2008 Jan 31;451(7178):591-5. doi: 10.1038/nature06531. Nature. 2008. PMID: 18235503 Free PMC article.
-
X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.Biochemistry. 2020 Feb 4;59(4):627-634. doi: 10.1021/acs.biochem.9b00971. Epub 2020 Jan 13. Biochemistry. 2020. PMID: 31894969 Free PMC article.
-
Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.J Phys Chem B. 2013 May 23;117(20):6042-51. doi: 10.1021/jp312396q. Epub 2013 May 9. J Phys Chem B. 2013. PMID: 23594107
-
Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.Mini Rev Med Chem. 2014;14(10):819-30. Mini Rev Med Chem. 2014. PMID: 25342196 Review.
-
Flu channel drug resistance: a tale of two sites.Protein Cell. 2010 Mar;1(3):246-58. doi: 10.1007/s13238-010-0025-y. Epub 2010 Feb 23. Protein Cell. 2010. PMID: 21203971 Free PMC article. Review.
Cited by
-
Real-time tracking of drug binding to influenza A M2 reveals a high energy barrier.J Struct Biol X. 2023 Jun 7;8:100090. doi: 10.1016/j.yjsbx.2023.100090. eCollection 2023 Dec. J Struct Biol X. 2023. PMID: 37363040 Free PMC article.
-
Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.Curr Opin Struct Biol. 2011 Feb;21(1):68-80. doi: 10.1016/j.sbi.2010.12.002. Epub 2011 Jan 17. Curr Opin Struct Biol. 2011. PMID: 21247754 Free PMC article. Review.
-
3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.J Med Chem. 2013 Nov 27;56(22):9265-74. doi: 10.1021/jm401340p. Epub 2013 Nov 15. J Med Chem. 2013. PMID: 24237039 Free PMC article.
-
Some remarks on protein attribute prediction and pseudo amino acid composition.J Theor Biol. 2011 Mar 21;273(1):236-47. doi: 10.1016/j.jtbi.2010.12.024. Epub 2010 Dec 17. J Theor Biol. 2011. PMID: 21168420 Free PMC article.
-
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.J Med Chem. 2014 Jul 10;57(13):5738-47. doi: 10.1021/jm5005804. Epub 2014 Jun 30. J Med Chem. 2014. PMID: 24941437 Free PMC article.
References
-
- Helenius A. Unpacking the incoming influenza virus. Cell. 1992;69:577–578. - PubMed
-
- Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has ion channel activity. Cell. 1992;69:517–28. - PubMed
-
- Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, Paulshock M, Watts JC, Wood TR, Hermann EC, Hoffmann CE. Antiviral Activity of 1-Adamantanamine (Amantadine) Science. 1964;144:862–3. - PubMed
-
- Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. Jama. 2006;295:891–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources